Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03373916 · ClinicalTrials.gov registry record · NA
Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults
A NA study of Suicidal Ideation, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 455
- Enrollment target
- 3
- Study locations
NCT03373916: Completed NA study of Suicidal Ideation, sponsored by University of Michigan.
NCT03373916 is a NA study of Suicidal Ideation that has completed, run by University of Michigan. The registered enrollment target is 455 participants, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (74% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03373916, a NA study of Suicidal Ideation, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 455 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a single-blind, randomized controlled trial to test the effectiveness of a peer mentorship intervention (PREVAIL) for reducing suicide risk compared to enhanced usual care among participants (N=455) at high-risk for suicide recruited from inpatient psychiatric units.
Primary Outcome
Number of participants reporting any suicide attempt, as reported on the Columbia Suicide Severity Rating Scale (CSSRS). The definition of suicide attempt for the primary outcome will consist of any actual suicide attempt, aborted suicide attempt, or interrupted suicide attempt reported on the CSSR-S.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Peer mentorship
Study Locations (3)
Michigan
- University of Michigan Inpatient Psychiatry Unit - Ann Arbor
- Henry Ford Kingswood Hospital - Ferndale
- Henry Ford Macomb Hospital - Mount Clemens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 455 participants |
| Start Date | 2018-06-22 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT03373916 record still lists
NCT03373916 is an interventional study that assigns participants to a tested intervention. The registered 455 participants enrollment target is mid-sized for trials with a published cap, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (74% higher).
The record links to 1 condition, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT03373916 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03373916 about?
NCT03373916 is a clinical study titled "Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults". This is a single-blind, randomized controlled trial to test the effectiveness of a peer mentorship intervention (PREVAIL) for reducing suicide risk compared to enhanced usual care among participants (N=455) at high-risk for suicide recruited from inpatient psychiatric units.
What is the current status of trial NCT03373916?
This trial is currently completed. It is a NA study. The enrollment target is 455 participants. The study started on 2018-06-22. Estimated completion is 2023-09-30.
What conditions does trial NCT03373916 study?
This clinical trial studies the following conditions: Suicidal Ideation.
What interventions are being tested in trial NCT03373916?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Peer mentorship (BEHAVIORAL).
Who is sponsoring clinical trial NCT03373916?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03373916 being conducted?
This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03373916's enrollment target sits among peer trials
455 13th of 84 higher than 72 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05541016 · 455 participants · Phase 2
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
- NCT06079346 · 455 participants · Phase 2
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer
- NCT06504446 · 455 participants · Phase 2
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
- NCT06725030 · 455 participants
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI